Investigational vaccine protected monkeys from HIV-like virus

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke research team led by Dr. Haynes used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.
More …